We are live on
!
Find out more
BRA
Biechele Royce Advisors Portfolio holdings
AUM
$303M
1-Year Est. Return
20.64%
This Fund
S&P 500
This Quarter
Est. Return
-2.05%
1 Year Est. Return
+20.64%
3 Year Est. Return
+39.24%
5 Year Est. Return
+125.34%
10 Year Est. Return
–
AUM
$271M
AUM Growth
-$15.9M
(-5.5%)
Cap. Flow
-$7.58M
Cap. Flow
% of AUM
-2.8%
Top 10 Holdings %
Top 10 Hldgs %
55.72%
Holding
72
New
2
Increased
21
Reduced
33
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.59M |
| 2 |
Robert Half
RHI
|
+$1.16M |
| 3 |
Medtronic
MDT
|
+$743K |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$678K |
| 5 |
United Parcel Service
UPS
|
+$524K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.76M |
| 2 |
BorgWarner
BWA
|
+$1.75M |
| 3 |
Airbnb
ABNB
|
+$840K |
| 4 |
MSC Industrial Direct
MSM
|
+$600K |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$518K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.93% |
| 2 | Industrials | 20.41% |
| 3 | Healthcare | 20.01% |
| 4 | Financials | 11.71% |
| 5 | Consumer Discretionary | 7.38% |
Similar funds
S
OHCM
E
CHA
BFA
IF
BWM
T
Biechele Royce Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Biechele Royce Advisors held 72 positions worth $271M, down 5.5% from $287M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Biechele Royce Advisors's Q3 2023 filing shows 2 new, 21 increased, 33 reduced and 7 closed positions. Its largest new stake was Vanguard Ultra-Short Bond ETF: 8,100 shares worth $398K. The largest sale was Bristol-Myers Squibb, an estimated $6.76M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.
- Biechele Royce Advisors's largest Q3 2023 buy was Vanguard Ultra-Short Bond ETF: 8,100 shares worth $398K.
- Biechele Royce Advisors added most to Charles Schwab in Q3 2023, an estimated $1.59M increase.
- Biechele Royce Advisors's biggest Q3 2023 reduction was BorgWarner, cutting an estimated $1.75M.
- Biechele Royce Advisors fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $6.76M.
- Biechele Royce Advisors's ten largest holdings make up 56% of its $271M portfolio in Q3 2023.
- Biechele Royce Advisors opened 2 new positions and closed 7 in Q3 2023.
- Biechele Royce Advisors's portfolio value fell 5.5% quarter-over-quarter to $271M.
Based on Biechele Royce Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.